Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase®
Clinicians should pay particular attention when managing individuals needing these drugs, especially if vulnerable and requiring polytherapy.
Authors
- Ugo Moretti (ORCID: https://orcid.org/0000-0001-5108-5807)
- Guido Mannaioni (ORCID: https://orcid.org/0000-0002-8273-7377)
- Gianluca Trifirò (ORCID: https://orcid.org/0000-0003-1147-7296)
- Nicoletta Luxi (ORCID: https://orcid.org/0009-0009-2615-0756)
- Giada Crescioli (ORCID: https://orcid.org/0000-0002-1071-6120)
- Alfredo Vannacci (ORCID: https://orcid.org/0000-0001-5259-2026)
- Stefano Fumagalli (ORCID: https://orcid.org/0000-0002-6950-3875)
- Elena Arzenton (ORCID: https://orcid.org/0000-0002-9778-1522)
- Niccolò Lombardi (ORCID: https://orcid.org/0000-0002-9666-0438)
- Roberto Bonaiuti (ORCID: https://orcid.org/0000-0001-9644-499X)
- Costanza Cacini
Institutions
- University of Verona (IT)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Agenzia Regionale di Sanità della Toscana (IT)
- University of Florence (IT)
Publication Details
- Journal
- Aging Clinical and Experimental Research
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1007/s40520-025-03025-4
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Università degli Studi di Firenze